News Focus
News Focus
icon url

flipper44

02/01/24 4:49 PM

#669349 RE: FeMike #669345

You call LP a liar, you call retail competent and not competent. You know damn well this company is getting pounded right now, and it has nothing to do with retail.

We are literally a few months from approval, in my opinion, and you know damn well BP can calculate future near term, mid term and long term projected revenue, but jerks like you want a depleted retail that are trying to keep the company afloat to fight, MM, assholes like you, etc to be the excuse for a low corporate valuation?

You don’t get it. You can pound this company, but their future revenues are still easily calculated, but why am I trying to explain this to someone who can’t tell “substantially all” from “all.”
icon url

dennisdave

02/01/24 5:11 PM

#669372 RE: FeMike #669345

Kite Pharma had the same problem, too low valuation before they could be bought by a large pharma. So their M&A broker hired a PR pumping firm that started rumors of Kite being acquired which promoted the SP x3. After that Gliead was able to buy Kite
icon url

CrashOverride

02/01/24 10:35 PM

#669448 RE: FeMike #669345

Big Pharma cares about future revenue. DCVax provides a greenfield market. They will pay or all of that cash will be in our pockets alone. Too bad you sold your 5 shares!